ADIMAB
Adimab's integrated antibody discovery and optimization platform provides unprecedented speed from antigen to purified, full-length human IgGs. Adimab offers fundamental advantages by delivering diverse panels of therapeutically relevant antibodies that meet the most aggressive standards for affinity, epitope coverage, species cross-reactivity and expressability. Adimab enables its partners to rapidly expand their biologics pipelines through a broad spectrum of technology access arrangements.
ADIMAB
Industry:
Biotechnology Collaboration Health Care Therapeutics
Founded:
2007-05-01
Address:
Lebanon, New Hampshire, United States
Country:
United States
Website Url:
http://www.adimab.com
Total Employee:
101+
Status:
Active
Contact:
(603) 643-7110
Email Addresses:
[email protected]
Total Funding:
45.48 M USD
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta Domain Not Resolving Apple Mobile Web Clips Icon Google Font API Google Tag Manager WordPress Google Analytics Global Site Tag IPv6
Similar Organizations
Excision BioTherapeutics
Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.
XOMA
XOMA is at the forefront of antibody discovery and development, one of the most powerful and transformative fields of drug innovation
Current Advisors List
Current Employees Featured
Founder
Investors List
Lux Capital
Lux Capital investment in Venture Round - Adimab
SV Health Investors
SV Health Investors investment in Series F - Adimab
Polaris Partners
Polaris Partners investment in Series F - Adimab
Google Ventures
Google Ventures investment in Series F - Adimab
Google Ventures
Google Ventures investment in Series D - Adimab
Polaris Partners
Polaris Partners investment in Series D - Adimab
Borealis Ventures
Borealis Ventures investment in Series D - Adimab
OrbiMed
OrbiMed investment in Series D - Adimab
SV Health Investors
SV Health Investors investment in Series D - Adimab
SV Health Investors
SV Health Investors investment in Series C - Adimab
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2021-04-19 | Invivyd | Adimab investment in Series C - Invivyd | 336 M USD |
| 2020-07-16 | Invivyd | Adimab investment in Series A - Invivyd | 50 M USD |
Key Employee Changes
| Date | New article |
|---|---|
| 2022-05-09 | Adimab Announces Promotions of New Chief Executive Officer and President |
Official Site Inspections
http://www.adimab.com Semrush global rank: 4.7 M Semrush visits lastest month: 1.97 K
- Host name: 19.98.212.35.bc.googleusercontent.com
- IP address: 35.212.98.19
- Location: United States
- Latitude: 38.6583
- Longitude: -77.2481
- Timezone: America/New_York
More informations about "Adimab"
Adimab Management Team | Org Chart - RocketReach
Adimab is the most successful antibody discovery company in the industry, with 450+ discovery campaigns and 55+ clinical programs created with more than 100 partners. Our unique, yeast …See details»
Homepage - Adimab
Adimab’s best-in-class therapeutic discovery capabilities are made possible by our proprietary yeast-based platform, utilizing fully human synthetic diversity and immunized diversity to …See details»
Adimab's Leadership Team - Team members and org chart - The Org
The leadership team at Adimab has a wide range of experience in many different industries. Business development, human resources, banking, and pharmaceuticals are all represented. …See details»
Who We Are - Adimab
Ryan McGovern is the Chief Financial Officer of Adimab and has been with the company since 2010. Before joining Adimab, Mr. McGovern served as Advisory Council for Live Free and …See details»
Platform - Adimab
Adimab’s best-in-class capabilities are made possible by combining our proprietary technology with our vast operational experience. De novo antibody discovery and optimization Adimab …See details»
Adimab - Crunchbase Company Profile & Funding
Adimab's integrated antibody discovery and optimization platform provides unprecedented speed from antigen to purified, full-length human IgGs. Adimab offers fundamental advantages by …See details»
Adimab - The Org
Adimab. 1 follower ‌ Adimab is an antibody discovery and optimization platform, developing full-length human Immunoglobulin Gs. ...See details»
Adimab - LinkedIn
Adimab | 7,092 followers on LinkedIn. Premier Human Antibody Discovery and Engineering Company | Adimab is the most successful antibody discovery company in the industry, with …See details»
Technology - Adimab
Adimab has optimized over a thousand individual antibodies on the basis of specificity, potency, and/or developability. This robust process relies on AI and ML-guided library diversities, facile …See details»
Adimab 2025 Company Profile: Valuation, Funding & Investors
Adimab General Information Description. Developer of yeast-based therapeutic human antibodies designed to improve the quality of the therapeutic lead. The company's therapeutic human …See details»
ADIMAB, LLC | TREA
Organization. LEBANON, NH, US Business Address 16 Cavendish Ct Lebanon NH 03766 603-646-9245 Mailing Address 16 Cavendish Ct Lebanon NH 03766 ... Adimab, LLC Laura M. …See details»
Adimab Company Profile | Management and Employees List
Adimab Profile and History. Adimab is the leading provider of therapeutic antibody discovery and engineering technologies. This includes nave discovery from synthetic libraries in yeast or B …See details»
Adimab - Contacts, Employees, Board Members, Advisors
Organization. Adimab . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. ... Adimab has 8 current employee profiles, including Co …See details»
Press Releases - Adimab
Jan 9, 2024 Adimab, LLC, the global leader in the discovery and optimization of fully human monoclonal and bispecific antibodies, today announced that it has extended its Adimab …See details»
Adimab Company Profile - Office Locations, Competitors, Revenue …
Adimab is a biotechnology company that provides a discovery platform functioning as a synthetic human immune system. It helps to develop antibody therapeutics across a range of medical …See details»
Adimab LLC Business Operations, SWOT, PESTLE, Porters Five
Mar 4, 2025 Figure 1: Adimab LLC - Head Office - Country Figure 2: Adimab LLC - Key Subsidiaries Figure 3: Adimab LLC - SWOT Analysis Figure 4: Competing Players *Note: We …See details»
Adimab: Revenue, Worth, Valuation & Competitors 2025
About Adimab. Adimab is a Biotech related company founded in 2007 and based in Lebanon with 166 employees an estimated revenue of $32.2M, and. It has 10 competitors including …See details»
Adimab: Contact Details and Business Profile - RocketReach
Adimab is the most successful antibody discovery company in the industry, with 450+ discovery campaigns and 55+ clinical programs created with more than 100 partners. Our unique, yeast …See details»
Adimab: Culture - LinkedIn
Adimab | 5,991 followers on LinkedIn. Premier Human Antibody Discovery and Engineering Company | Adimab is the most successful antibody discovery company in the industry, with …See details»
Adimab - VentureRadar
Adimab’s integrated antibody discovery and engineering platform provides unprecedented speed from antigen to purified, full-length human IgGs. Adimab offers fundamental advantages by …See details»